scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding scPharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 38 | 40 | +2 |
| Shares | 15.7M | 14.0M | −1.67M (−10.7%) |
| Value | $75.9M | $91.3M | +$15.4M (+20.2%) |
New holders (4)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 50,625 | $330.0K | 0.02% |
| Ritholtz Wealth Management | 15,000 | $98.0K | 0.01% |
| Envestnet Asset Management Inc | 14,186 | $92.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 11,573 | $75.0K | 0.00% |
Sold out (2)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Virtu Financial LLC | 10,999 | $53.0K |
| UBS Group AG | 2,152 | $10.0K |